This study was performed to develop mouse anaphylaxis model using ovalbumin (OA) as an antigen, with no adjuvant, and an intravenous route of administration. OA at dose levels from 0.5 to 500 mg/kg was injected 3 times into the tail vein of female CD-1 (ICR) mice at 4-day intervals. Clinical signs and extravasation of Evans blue dye (vascular permeability) were observed, serum histamine levels and airway resistance were measured, and histopathological examinations were performed. Furthermore, to detect serum IgE and IgG, heterologous and homologous passive cutaneous anaphylaxis tests were performed. Additionally, strain differences in susceptibility to OA anaphylaxis was examined with 3 mouse strains: ICR, BALB/c and C57BL/6 mice. Shortly after the 3 rd injection, most of the animals exhibited systemic anaphylactic signs including death, and this was accompanied by increases in vascular permeability, plasma histamine levels, and airway resistance. Four days after the 2 nd injection, anti-OA IgE and IgG were detected in sera of mice injected with 0.5 and 5.0 mg/kg or higher doses of OA, respectively. Histological findings included: congestion in many tissues; detachment of mucosal epithelial cells in the gastrointestinal tract; enhanced death, decreased numbers of lymphocytes, and increased numbers of macrophages in the lymphoid tissues. ICR mice were shown to be most susceptible to the OA anaphylaxis of the 3 mouse strains examined. In conclusion, the results demonstrate that 3 intermittent intravenous injections of OA without adjuvant at 4-day intervals can induce anaphylactic shock in mice, in particular, most effectively in ICR mice, and that the anaphylaxis is characterized by specific IgE and IgG production. (J Toxicol Pathol 2007; 20: 237-244) 
Introduction
Allergic reactions are classified into the four types (types I to IV) described by Gell and Coombs (1963) 1 , and among these types, type I allergy (immediate type hypersensitivity) can lead to acute death in rare cases. Anaphylactic reactions of the type I allergy are induced by interaction between antigen and antigen-specific homocytotropic antibodies (e.g. human IgE) located on mast cells or basophils, resulting in chemical mediator releases from the cells 2 . Thus, the induction of an antigen-specific IgE response is a prerequisite for the development of anaphylaxis in humans. In rodents, IgG antibodies of the IgG 1 isotype as well as IgE antibodies can elicit an anaphylactic reaction 3 -6 . Several types of mouse anaphylaxis models have been developed to investigate the immediate type hypersensitivity to several antigens, such as foods, respiratory allergens, and pharmaceuticals. In these models, mice are generally sensitized by treatment with allergens via several routes, such as intraperitoneal, subcutaneous, and topical administration. The sensitization route in these models is sometimes selected to match the exposure route of an allergen in humans, for instance an oral route for food allergens or inhalation for respiratory allergens [7] [8] [9] [10] . In these animal models, adjuvants have always been used with antigens to induce susceptible immune responses by intraperitoneal or subcutaneous injections. The adjuvants can enhance immunogenicity in two different ways. First, the adjuvants convert soluble protein antigens into particulate materials, which are more readily ingested by antigen-presenting cells. Second, when the adjuvant contains bacteria or bacterial products, such as Freund's complete adjuvant, the products may stimulate macrophages or dendritic cells to become more effective antigenpresenting cells. To the best of our knowledge, an intravenous route has not been used for both the sensitization and challenge phases in animal models. This is because antigens injected or infused directly into the bloodstream are free of the aggregation that contributes to the uptake of antigens by antigen-presenting cells, and tend to induce unresponsiveness or tolerance unless they bind to host cells. Moreover, the mixture of an antigen and an adjuvant is always in suspension or emulsion form, and can not possibly be administered intravenously. In the clinical field, however, some patients receiving an intravenous injection of a pharmaceutical alone, especially ones comprising high molecular weight compounds and biopharmaceuticals, have exhibited anaphylactic reactions. Therefore, there is a need for an animal model that actually reflects the clinical situation, particularly intravenous administration.
This study was designed to develop and analyze a novel mouse anaphylaxis model by sensitization with intravenous injections of ovalbumin (OA) alone. Here we report that anaphylactic reactions were induced in mice, and especially that the OA-induced anaphylaxis was characterized by the production of specific IgE antibody despite a short sensitization period with no adjuvant. Furthermore, we report the histological findings for the OA anaphylaxis.
Materials and Methods

Chemicals
OA was purchased from Sigma Chemical Co. (St. Louis, MO, USA), and succinylcholine and Evans blue dye were purchased from Tokyo Kasei Kogyo Co., Ltd. (Tokyo, Japan) and Nacalai Tesque Inc. (Kyoto, Japan), respectively.
Animals
One hundred and forty-nine female CD-1 (ICR) [including 10 mice as the recipients in the passive cutaneous anaphylaxis (PCA) test], 29 BALB/c (4), and 29 C57BL/6 (4) mice were supplied by Charles River Japan Inc., Yokohama, Japan. Eighteen female CD (SD) rats were provided from the same supplier as the recipients in the PCA test. During the study period, the animals were housed in an animal room maintained at 23 ± 2°C and 55 ± 20% relative humidity with a 12-h cycle of light and dark. They were allowed free access to commercial pellet diet (F-2, Funabashi Farm Co., Ltd., Funabashi, Japan) and tap water. The animals were assigned to the test groups by a stratified randomization procedure based on body weight so that all groups had similar mean body weights. The animals were received at 8 to 10 weeks of age, and used in experiments from 10 to 11 weeks of age.
All experimental procedures were performed in accordance with the Law Concerning The Protection and Control of Animals, and Standards Relating to The Care and Management of Experimental Animals, in Japan.
Induction of systemic anaphylactic reaction in mice
OA at 0.5, 5, 50, or 500 mg/15 ml saline/kg was injected into the tail vein of ICR mice (n=5) at the rate of 2 ml/min, 3 times at 4-day intervals. Control animals received saline. Body weights were measured just before each injection. Anaphylactic signs were judged according to the criteria of Suzuta (1969) 11 and graded as follows: grade 0, no change; grade 1, development of respiratory depression only; grade 2, development of respiratory depression plus decreased locomotor activity, prone position or cyanosis; grade 3, convulsion and death. The clinical signs were judged to be positive for the anaphylactic reaction when the signs were graded 2 or higher.
To evaluate increased vascular permeability in OAsensitized mice (n=10; 5 for control) showing the anaphylactic responses, the mice were injected with 0.2 ml of 0.5% Evans blue dye solution just before the 3 rd injection of saline (control) or OA at 0.5 or 5 mg/kg. The animals were euthanized by carbon dioxide asphyxia 10 min after the final injection, and extravasation of the dye into the trunk subcutaneous tissue was grossly observed.
Measurement of plasma histamine concentration
ICR mice (n=8) were similarly, intravenously injected with OA at 0 (control), 0.5 or 5 mg/kg, 3 times at 4-day intervals. Approximately 5 min after the 3 rd injection, blood was withdrawn from the abdominal vena cava of the animals under ether anesthesia into a blood collection tube (MICROTAINER, Becton Dickinson and Company, NJ, USA) containing EDTA-2K. Plasma was separated by centrifugation at 1700 g for 15 min at 4°C for measurement of plasma histamine concentrations with an ELISA Kit (ICN Pharmaceutical, CA, USA).
Measurement of airway resistance
ICR mice (n=5) were intravenously injected with 0 (control), 0.5 or 5 mg/kg of OA, 2 times at a 4-day interval. Four days later, the trachea of the animal was cannulated and connected to a rodent ventilator (Model 683, Harvard Apparatus, Southnatick, MA, USA) with an in-line pressure transducer (Model DP45-28, Validyne Engineering Corp., Northrige, CA, USA) that was coupled to a pulmonary mechanics analyzer (Model 6, Buxco Electronics Inc., Sharon, CT, USA). Flow was determined by measuring the difference in pressure (Model DP45-28) across 6 layers of 400-mesh wire cloth covering a 1.3 cm hole in a plethysmograph box (Model Plyan-M, Buxco Electronics Inc.). The animals were placed in the box and then ventilated at 120 strokes/min with a stroke volume of 0.3 mL after neuromuscular block with 10 mg/kg of succinylcholine. After a stable baseline of airway resistance was established, saline or OA at 0.5 or 5 mg/kg was injected into the tail vein, and changes in airway resistance were monitored. Data collected 5 min after the challenge injection are expressed as percent changes from the baseline airway resistance value for each animal.
PCA test
ICR mice (n=5) were intravenously injected with saline (control) or OA at the same 4 doses as those used for induction of the anaphylactic reaction, 2 times at a 4-day interval. Sera were collected 4 days (just before the 3 rd injection) after the 2 nd injection to detect IgG and IgE specific to OA by homologous and heterologous PCA tests, respectively, as follows.
Homologous PCA test on mice: Fifty microliters of sera diluted 5-fold were intradermally injected into the dorsal skin of depilated recipient mice (n=2) for passive sensitization. Two hours later, the animals were injected intravenously with 0.2 ml of 0.5% Evans blue dye solution, followed by an intravenous challenge injection of saline (control) or OA 5 mg/kg. All of the recipient animals were euthanized by carbon dioxide asphyxia 30 min after the challenge injection, and the extent of the blueing region around the intradermal injection site was measured. The PCA was judged to be positive when the blueing region had a diameter (long plus short) of 5 mm or more.
Heterologous PCA test on rats: Except for the use of 100 µl of 5-fold diluted sera for the passive sensitization, SD rats instead of ICR mice as the recipients, and 0.5 ml of 1% Evans blue, and that the challenge injection was performed 24 h after the passive sensitization, the same procedures were done as for the homologous PCA test.
Histological examination
To differentiate histological findings between dead and surviving animals, 5 and 20 ICR mice were intravenously injected with saline (control) and OA 5 mg/kg, respectively, 3 times at 4-day intervals. Fifteen of the animals died between 15 and 66 min following the last administration of OA. From among them, 5 dead animals were randomly selected and necropsied, and subsequently the 5 surviving animals and 5 control animals were euthanized in sequence by exsanguination under ether anesthesia and subjected to necropsy. The gastrointestinal tract, thymus, spleen, mesenteric lymph nodes, lung, trachea, liver, gall bladder, pancreas, kidney, urinary bladder, ovary, uterus, heart, brain, pituitary gland, thyroid gland, and adrenal gland were fixed in buffered formalin. All of the tissues were embedded in paraffin wax, sectioned, and stained with hematoxylin and eosin for light microscopy. The remaining dead animals were discarded.
Strain difference in susceptibility to OA anaphylaxis
BALB/c and C57BL/6 mice (n=5) were intravenously injected with 5, 15, or 50 mg/kg of OA, 3 times at 4-day intervals, and judged for anaphylaxis induction. Other animals of each strain (n=5) were given 15 or 50 mg/kg of OA and tested for PCA using recipient mice (n=2) and rats (n=2).
Statistical analysis
The quantitative data of body weight, histamine concentration, and airway resistance are presented as the group means ± SD. The homogeneity of variance was analyzed by Bartlett's test. When the variance was homogenous, one-way analysis of variance was used, and if a significant difference was obtained, Dunnett's test was further used to analyze the difference between the control and OA groups. When the variance was not homogenous the Kruskal-Wallis's test was used, and if a significant difference was obtained, a non-parametric test of Dunnetttype was used. A p value of less than 5% was considered to show significance. The group means of the grades of clinical signs were calculated, but not subjected to statistical analysis.
Results
Induction of systemic anaphylactic reaction in mice
There were no differences in body weights between the control and OA-treated groups at any injection point. None of the mice exhibited any clinical signs after the 1 st and 2 nd intravenous injections of OA at any dose level. However, the animals given the 3 rd injection of 0.5 mg/kg (3/5 mice positive for anaphylaxis) or higher (all mice positive) showed anaphylactic signs, such as respiratory depression, a decrease in locomotor activity, cyanosis, ptosis and prone position within a few minutes after the injection. Subsequently 3/5, 2/5, and 3/5 animals died at doses of 5, 50, and 500 mg/kg, respectively (Table 1) . Ten min after the 3 rd injection of OA, extravasation of Evans blue dye into the subcutaneous tissue was observed in 4/10 and 10/10 animals at 0.5 and 5 mg/kg, respectively ( Table 1) .
Plasma histamine concentration and airway resistance
Plasma histamine concentrations and airway resistance data obtained at 5 min after the 3 rd injection of OA are presented in Table 2 . The histamine concentrations were approximately 30-fold and 380-fold higher than the control values in the 0.5 and 5 mg/kg OA injection group mice, respectively, with statistical significance at 5 mg/kg. The airway resistance also increased dose-dependently, with approximately 15% and 25% higher values than those of the pre-dose baselines at 0.5 and 5 mg/kg, respectively, with statistical significance at 5 mg/kg.
PCA test
The detection of OA-specific IgG and IgE in sera collected 4 days after the 2 nd injection of OA was attempted by homologous and heterologous PCA tests in mice and rats, respectively. As shown in Table 3 , anti-OA IgG was measurable in mice receiving 5 mg/kg or higher. Furthermore, IgE was also detected at all dose levels, indicating that IgE was preferentially produced by sensitization even with the lowest OA dose of 0.5 mg/kg.
Histological findings
Histological findings are listed below and in Table 4 . In the OA-treated group, the changes observed only in dead mice are described as A) below, whereas those observed in both the dead and surviving animals, or survivors only are as described B). No changes were seen in the control group.
Gastric mucosa: A) congestion with mildly edematous serosa; B) detachment of epithelial cells and/or surface tissues (Fig. 1) , and multifocal hemorrhage covered by no surface tissues (Fig. 2 ). Duodenal mucosa: A) congestion; B) detachment of epithelial cells. Cecal mucosa: B) congestion. Colonic and Rectal mucosa: B) detachment of epithelial cells. Thymus: B) increased numbers of dead lymphocytes having shrunken and fragmented nuclei in the cortex, associated with macrophages ( Fig. 3) . Spleen: A) decreased numbers of lymphocytes with increased numbers of germinal centers containing many dead cells in white pulp (Fig. 4) ; B) congestion of red pulp. Mesenteric lymph nodes: B) increased numbers of macrophages especially in medullary sinus (Fig. 5) . Lung: A) congestion, sometimes accompanied by many neutrophils and/or lymphocytes in blood vessels. Trachea, Liver, Pancreas, Kidney (Fig. 6 ), Urinary bladder, Uterus, Adrenal glands, and Brain: A) congestion.
Strain difference in susceptibility to OA anaphylaxis
In BALB/c mice, anaphylactic reactions were observed at doses of both 15 and 50 mg/kg OA, but not at 5 mg/kg, with incidences of 3/5 and 5/5, respectively ( Table 5 ). In contrast, C57BL/6 mice exhibited anaphylactic responses only at 50 mg/kg (4/5 animals). As for specific antibodies, anti-OA IgG was detected in 1/5 and 3/5 BALB/c mice at 15 and 50 mg/kg, respectively, but not in C57BL/6 mice, while IgE was detected in 1/5 and 3/5 BALB/c mice, and in 1/5 and 5/5 C57BL/6 mice at 15 and 50 mg/kg, respectively. These data indicate lower susceptibilities to OA anaphylaxis in BALB/c and C57BL/6 mice than in ICR mice.
Discussion
In the present study, female ICR mice were given 3 intermittent intravenous injections of OA at 4-day intervals to induce anaphylaxis, because consecutive-day injections could lead to immune tolerance 12 . Although no clinical signs were observed after the 1 st and 2 nd injections, respiratory depression, decreased locomotor activity and cyanosis were observed a few minutes after the 3 rd injection, and some animals died. To confirm whether these clinical responses were actually caused by anaphylaxis or not, we measured several anaphylactic parameters and OA-specific antibodies (IgG and IgE). Plasma histamine concentrations increased and extravasation of Evans blue dye into the subcutaneous tissues was observed in mice after the 3 rd injection of OA. These findings are consistent with a report that the chemical mediators, histamine and leukotrienes, are released from mast cells, and then extravasation of plasma components takes place due to increased vascular permeability in mice with anaphylactic shock 13 . Platelet (PLT)-activating factor (PAF) may also contribute to the onset of the shock symptoms, because PAF released from basophils, and probably mast cells, has been reported to make PLTs coagulate and degranulate releasing inflammatory mediators including 5-hydroxytryptamine 14, 15 . Furthermore, being consistent with reports that airway constriction is induced by the release of chemical mediators in anaphylaxis 16, 17 , airway resistance increased in the mice of the present study after the 3 rd injection of OA, and this is considered comparable with the clinical signs of respiratory depression. In PCA tests, OA-specific IgE and IgG were detected in sera collected from mice just before the 3 rd injection. This definitely proves that the intermittent injections of OA induced systemic anaphylaxis, based on the description that anaphylactic shock involves the production of antigenspecific IgE in humans, and IgE and IgG in rodents. Thus, this novel OA anaphylaxis model was produced in the mouse by 3 intermittent intravenous OA injections at 4-day intervals in the absence of adjuvant.
Histological changes observed only in dead mice are summarized as follows: 1) congestion in many tissues; 2) decreased number of lymphocytes in the spleen with increased number of germinal centers in white pulp; 3) many neutrophils and/or lymphocytes in pulmonary blood vessels. Of these findings, the congestion observed in many tissues may correspond to the visceral congestion found in anaphylactic patients dying of vascular collapse (a presumptive loss of intravascular blood volume), which is not preceded by respiratory distress, leading to some electrocardiographic abnormalities 18 . Moreover, many neutrophils in pulmonary blood vessels, and additionally edema have also been reported in rabbits and monkeys 19, 20 . Mast cells are considered as important for indicating changes of the heart and lungs, and for the death of animals as follows: increased plasma histamine levels and acute pulmonary emphysema have been seen only in dead guinea pigs sensitized and challenged by intracardial OA 21 ; degranulation of mast cells, increased heart rate, and decreased compliance and conductance of the lung have been reported in mice infused with goat anti-mouse IgG 22 . In the present study, therefore, vascular collapse is considered to be the main cause of death of the mice, and death was shown to be accompanied by decreased numbers of lymphocytes in the spleen, and the aforementioned increases in airway resistance and serum histamine levels with increased permeability of the subcutaneous microvasculature.
In the present study, detachment of mucosal epithelial cells in the gastrointestinal tract was observed in dead and surviving mice. There have been many reports on histological changes in the gastrointestinal tract, which were induced by OA anaphylaxis with an adjuvant. Enhanced turnover of mucosal epithelial cells, enhanced degranulation of mast cells, and small ulcerative lesions have been observed in the stomach 23 . Following an oral OA challenge, infiltration of mast cells was seen in the intestine 1 h later, edema of villi at 3 h, eosinophil infiltration at 6 h, increased numbers of goblet cells at 12 h, and villous atrophy and lymphocyte infiltration at 24 h 24 . In addition, desquamation of epithelial cells, and tissue collapse have been observed at the villous tips in the jejunum and ileum 25 . Congestion and hemorrhage were also observed in the intestinal mucosa immediately after an injection of rat-bovine serum albumin (BSA) antibody-BSA complexes 26 . The changes observed in the present study are mostly consistent with the above reports. However, hemorrhage in the gastric mucosa was seen in the surviving, but not in the dead, animals, and this difference is considered to be due to chronological differences in euthanasia of the animals.
As anaphylactic changes in lymphatic tissues, decreased sizes of follicles, decreased numbers of lymphocytes, pyknotic and broken nuclei, and proliferating reticular cells, with phagocytosed nuclear fragments have been reported in the mesenteric and popliteal lymph nodes 27 . In the present study, increased numbers of dead lymphocytes and decreased numbers of lymphocytes were seen in the thymus and spleen, respectively, but not in the lymph nodes. The decreased lymphocyte numbers in the spleen implies enhanced migration of the cells into the peripheral blood, because the number of dead lymphocytes seemed not to be increased in the white pulp. In such atrophic white pulp, the number of germinal centers was increased, but it is unclear whether the germinal centers could function or not.
In the present study, strain differences in susceptibility to OA anaphylaxis were observed, and ICR mice exhibited the most susceptible response among the strains examined. Immune responses to antigens have been reported to be genetically controlled by the major histocompatibility complex region (H-2 region) on the chromosome [28] [29] [30] [31] [32] . Furthermore, the strain difference in producing specific anti-OA antibodies has been investigated in mice sensitized by intraperitoneal injections of OA with alum. Although ICR is not an inbred strain, the mice of this strain showed higher responses, producing more anti-OA IgG than BALB/c and C57BL/6 mice 33 . With respect to the other antigens, ICR mice have also been reported to exhibit anaphylactic reactions to horse-γ-globulin, poly Glu60Ala30Tyr10, and lysozyme at higher incidences than those seen in BALB/c and C57BL/6 mice 13 . Therefore, ICR mice are considered to be highly susceptible to anaphylactic reactions induced not only by OA, but also by the other antigens. Another possible factor for the strain differences observed in the present study is a difference in responses to chemical mediators. BSAinduced anaphylaxis in ICR mice has been reported to be inhibited by treatment with cyproheptadine, an inhibitor of both histamine and serotonin 13 , and ICR mice have been reported to be more susceptible to histamine than other mice strains 34 . Therefore, the strain differences in susceptibility to OA anaphylaxis seen in the present study are considered to be attributable to both a genetically higher ability to produce anti-OA antibody, and higher sensitivity to the mediators, histamine and/or serotonin, in ICR mice.
In conclusion, systemic anaphylactic reactions including death were induced in female ICR mice by 3 intermittent intravenous injections of OA alone at 4-day intervals, and the anaphylaxis was characterized by the production of specific serum IgE and IgG, despite the short sensitization period with no adjuvant. Histological findings included congestion in many tissues, detachment of mucosal epithelial cells in the gastrointestinal tract, increased numbers of dead lymphocytes in the thymus, decreased numbers of lymphocytes in the spleen, and increased numbers of macrophages in the medullary sinus of the lymph nodes. In addition, ICR mice were more susceptible to OA anaphylaxis than were BALB/c and C57BL/6 mice under the present experimental conditions. 
